Treatment of patients with T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.
Dosage: For adults the recommended dose is 1,500mg/m2 administered intravenously over two hours on days 1, 3 and 5 and repeated every 21 days. The recommended dose for children is 650mg/m2 administered intravenously over one hour daily for five consecutive days, repeated every 21 days. In clinical studies doses of 650mg/m2 and 1,500mg/m2 have both been used for patients aged 16 to 21 years, with similar efficacy and safety for both regimens.
Increlex IGF 1 LR3 10mg Per ml, 4ml vial
This kit equates to 40,000mcg of IGF